Invention Grant
- Patent Title: Human antibodies to GFR alpha3 and methods of reducing pain associated with GFR alpha3-related diseases
-
Application No.: US15382256Application Date: 2016-12-16
-
Publication No.: US10077311B2Publication Date: 2018-09-18
- Inventor: Susan D. Croll , Lynn Macdonald , Andrew J. Murphy
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: US NY Tarrytown
- Agency: FisherBroyles, LLP
- Agent Veronica Mallon; Cara L. Crowley-Weber
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; G01N33/53 ; A61K49/00 ; C12P21/08 ; C07K16/28 ; A61K45/06
Abstract:
The present invention provides antibodies that bind to human GFRα3 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GFRα3. The antibodies of the invention are useful for the treatment of diseases and disorders associated with one or more GFRα3 biological activities, including the treatment of acute or chronic pain conditions, or inflammatory conditions.
Public/Granted literature
- US20170096488A1 HUMAN ANTIBODIES TO GFR ALPHA3 AND METHODS OF USE THEREOF Public/Granted day:2017-04-06
Information query
